Maternal hypercoagulability is a possible cause of miscarriage during the 8 th and 9 th week of pregnancy, when the placenta replaces the yolk sac. We thus examined associations between putative markers of an acquired hypercoagulable state and the risk of first miscarriage. We conducted a case-control study comparing 743 women who miscarried in weeks 8 and 9 with 743 women who underwent a first provoked abortion, 
INTRODUCTION
thrombotic tendency in patients with primary (18) or secondary (19) antiphospholipid syndrome, and is involved in pregnancy failure (20) .
The objective of the present study was to determine whether women with a first episode of spontaneous pregnancy loss during the 8 th and 9 th week of gestation were more likely to have moderate levels of some hemostasis-related autoantibodies: traditional antiphospholipid antibodies (lupus anticoagulant and anticardiolipin antibodies), nontraditional antiphospholipid antibodies (anti-phosphatidylethanolamine, anti-2-glycoprotein I and anti-annexin V antibodies), anti-haemostasis-related key glycoproteins antibodies (anti-Tissue Factor, anti-thrombomodulin, anti-t-PA), or a moderate hyperhomocystenemia.
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Study participants.
Between September, 1996, and September, 2001, we carried out a matched casecontrol study at the university hospital of Nîmes, France, and in clinics belonging to the same administrative obstetrical network, which serves about 1 million inhabitants. This study was a part of our Mediterranean Abnormal Pregnancy study Program called NOHA 6 (Nîmes Obstetricians and Haematologists study 6 ).
We identified 1709 consecutive women, 19-31 years old hospitalized with a medically confirmed diagnosis of spontaneous abortion between the beginning of the 8 th and the end of the 9 th week of pregnancy (10 th and 11 th weeks of amenorrhea). Those with a blighted ovum on ultrasound exam (9%) or with chromosome abnormality in the conceptus caryotype (42%) were excluded, leading to study the potential inclusion of 923 women. These women, known to have a positive pregnancy test, had medical symptoms related to abortion which had occurred during the 10 th and 11 th weeks of amenorrhea.
Transvaginal ultrasound was performed before management to confirm spontaneous abortion (no heartbeat detection) but the embryonic size was not systematically evaluated (total length and biparietal diameter measured in 811 patients).
As abortion itself durably influences the levels of antiphospholipid antibodies (11), the control patients were consecutive women hospitalized for a provoked abortion performed between the beginning of the 8 th and the end of the 9 th week of pregnancy.
We assessed eligibility and performed clinical examinations on admission to hospital, but inclusion, informed consent, and blood collection took place at least 6 months (6-12 months) after the acute event.
For personal use only. on November 16, 2017. by guest www.bloodjournal.org From Lupus anticoagulants (LA) were detected with screening assays and were first identified by mixing studies using the normal pooled plasma, then confirmed by by high phospholipid concentrations using washed, ionophore-treated platelets. They were prepared as follows : citrated normal blood was centrifuged at 150 g for 15 minutes at room temperature. The platelet-rich plasma supernatant was centrifuged at 1,500 g for ten minutes at room temperature and the platelets were washed twice by suspension and centrifugation in a buffer consisting of 0.15 mol/L NaCl, 0.02 mol/L Tris, 0.001 mol/L For personal use only. on November 16, 2017. by guest www.bloodjournal.org From EDTA, 0.005 mol/L glucose, pH 7.5. The twice-washed platelets were resuspended at a concentration of 8 x 10 8 /ml in the same buffer, but without EDTA (buffer A). Activation was achieved by adding to 2 ml of platelet suspension 1 µl of a 5mmol/L solution of calcium ionophore A23187 in absolute ethanol (giving a final concentration of 2.5 µmol/L) and incubating for five minutes at room temperature. Buffer A, instead of platelet suspension, was treated the same way. The ionophore-treated platelets or buffer A were frozen in aliquots at -80°C for future use. Finally, the confirmation -study was performed using 50 µl ionophore-treated platelets or buffer A added to 100 µl of plasma and to 100 µl of the dRVVT reagent : the ionophore-treated platelets had been diluted in buffer A in order to obtain a dRVVT of 25 to 30 seconds when performed on the normal pooled Plasma anticardiolipin IgG and IgM antibodies were measured according to an adaptation of the in-house method which has been previously published by Reber et al.
(24). In brief, plates (Maxisorp, Nunc, Denmark) were coated with cardiolipin (50 µg/ml in methanol, Sigma, St. Louis, USA) or just with methanol (non specific binding wells) and incubated overnight at 4°C. Blocking and dilution solutions were PBS with 10% foetal calf serum. Blocking step was performed by incubation for 2 hours at room temperature. Plasma diluted 1 :100 were tested with coated and non coated plates. The anticardiolipin reactivity was assessed by using alkaline phosphatase-conjugated affinity-purified goat anti-human (Fc fragment specific) IgG or IgM antibodies (Jackson Immunoresearch Lab., West Grove, USA). Results were expressed in delta OD (the absorbency of non coated wells was subtracted from that of coated wells 
Variability control.
Due to the absence of standards in ELISAs other than anticardiolipin, day-to-day variability of the various assays had to be controlled. In the pre-development phase of a given solid-phase assay, we tested each normal individual plasma in a same run. For a given type of solid-phase assay, we thereafter used the slope value obtained with the normal plasma giving the highest activity in this assay, and with the normal pooled plasma, as references. They were run on each plate, leading, for a given type of ELISA, to corresponding "mean slope value of the normal pooled plasma" and "mean slope value of the normal highest activity". For a given plate, a 2 % difference between these two variability ratios led to discard the results and to test again. Finally, individual results obtained in a given plate were systematically divided by the mean value of the 2 corresponding variability ratios.
Each plasma was tested in triplicate and the obtained median values were used for statistical analysis.
Statistical analysis.
For personal use only. on November 16, 2017. by guest www.bloodjournal.org From First, we examined means and standard deviations of all biomarkers in cases and controls. To examine associations between biomarkers, we computed Spearman correlation coefficients (separately in cases and controls). Then, we categorized each continuous variable into four levels, corresponding to percentiles 1-80, 81-95, 96-99, and 100, among control subjects. All comparisons of cases and controls were conducted by means of methods for matched pairs: McNemar test and odds ratio for positive lupus anticoagulant, paired Mann-Whitney test for mean values of continuous variables, paired t-test for the 95% confidence interval on the mean difference between cases and controls, and conditional logistic regression for odds ratios corresponding to the three upper levels of the 4-level categorical variables (percentiles 81-95, 96-99, and 100, compared with percentiles 1-80). The latter models were repeated with each covariate coded as a continuous variable, to obtain a p value for linear trend across the four levels. Conditional logistic regression was also used to derive a multivariate model predicting spontaneous miscarriage (i.e., case status), from all available autoantibodies and homocysteine levels. Based on the final multivariate logistic regression model, we computed for each participant a propensity score for having a spontaneous miscarriage (this score corresponds to each participant's covariate levels, applied to the regression equation, and is expressed on a log-odds scale), and we used the proportion of pairs in which the case had a higher score than the control as an indication for the model's goodness-of-fit (this is an equivalent of the area under the receiver operating characteristic curve, applied to paired data). All p-values less than 0.05 were considered to be statistically significant.
RESULTS
We enrolled 743 case-control pairs of women, matched for age, total number of pregnancies and time elapsed since the occurrence of the abortion. No significant difference between cases and controls was found in terms of body mass index, cigarette smoking and oral contraceptive use ( Table 1) . The patients and controls were similar in terms of educational level, occupation and social class (data not shown). Women were primary aborters (pregnancy loss during the first pregnancy) or secondary aborters (first pregnancy loss during the second or third pregnancy): after classification of the women accordingly to the presence/absence of a previous successful pregnancy, our final analysis could not detect any significant heterogeneity in the results. No significant difference could be evidenced between women with loss of a first pregnancy and women with two successful pregnancies who lost the third one. Mean values of biomarkers were higher in cases than in controls, for about half of the variable considered (Table 3 ). This suggests a shift in the whole distribution, and not only an increased risk at the upper end of the distribution. The multivariate analysis identified six independent predictors of first spontaneous miscarriage during the 8 th and 9 th weeks of pregnancy: a positive lupus anticoagulant activity, and high levels of anticardiolipin IgM, anti-phosphatidylethanolamine IgM, antiannexin V IgG, anti-tPA IgG and homocysteine (Table 7) .
Most of lupus anticoagulant activities were positive using the aPTT based-assay and the dRVVT based assay (controls: 8 out of 10; cases: 42 out of 48). It was thus impossible, in our population of women, to evidence a specific risk associated with a positivity for one of these two types of assay system. The TTIT-based system was disappointing, being rarely positive (controls: 1; cases: 4), always in association with one of the two other assays. We also looked if it was possible to find a higher risk depending on the degree of positivity.
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The prolongation ratio (mixture clotting time) / (normal pool plasma clotting time) was used as an indicator but the values, in controls and cases, are roughly similar, with only, on the right side of the distributions, 3 cases and no control having ratios higher than 2. We thus could not evidence any clear gradation of risk associated with an increasing degree of positivity .
For each of the five continuous variables, the adjusted odds ratio increases as the variable value increases. The strongest risk factor is anti-tPA IgG, the 100 th percentile being associated with a 20-fold higher risk than percentiles 1-80, the two intermediate categories being associated with a 8-fold increased risk. There was a clear gradation of increasing risk associated with the 4 categories of homocysteinemia. For the 3 other variables, the highest category of values is associated with a 3 to 4-fold increased risk than the lowest one.
A prediction score based on this multivariate model was computed in cases and controls, and the propensity scores in cases and controls are shown in figure 1 . The predicted risk of miscarriage is higher in the case than in the control in 577 pairs (77.7%).
In these 577 cases, 536 (92.9%) had transvaginal ultrasound data compatible with a 10-11' weeks gestation failure.
We finally , for each of the 6 independent predictors, studied 20 cases and 20 controls 3 months after initial testing, including 10 cases and controls with an initial test in a category of values associated with a significant risk. This second test was performed before the end of the 12 th month after miscarriage, due to the fact that our threshold values had been defined for a blood sample taken before this date. In controls, this second blood sample was not associated with any move to another category of results, except in two women with an increased homocysteine, in a context of severe food restriction for weight loss. Four patients had a significant variation of at least one of the antibodies: however,
one month later, gave results in agreement with the initial ones. Two other patients had an enhancement of their homocysteine level which was secondary to the intake of drugs affecting homocysteine metabolism. These are not insubstantial changes. These are however changes which can be explained by the clinical context, pointing to the necessary careful knowledge and control of pre-analytical conditions for an adequate use of these tests.
DISCUSSION
Our matched case-control study identified, in women, some risk factors for a first episode of spontaneous abortion at the very early moment when the placenta replaces the yolk sac as an essential source of blood supply to the embryo. These risk factors are 
th weeks of pregnancy.
A main criticism should be the degree of credibility with which we have studied pregnancies that really failed at 8 and 9 weeks (10-11 weeks' gestation). Miscarriages can come to medical attention days or weeks after the embryo has expired. However, we have not studied patients with blighted ovum, i.e. with an absence of embryo, died several weeks earlier. Moreover, the available transvaginal ultrasonographic measurements are concordant with a 10-11 weeks' gestation failure in roughly 93 % of the patients, with an earlier failure in a maximum of 8.9% of them, which cannot explain the differences in the case-control pairs (higher risk in 78% of all cases). This massive orientation of the casecontrol pairs towards a higher risk in patients cannot be explained, too, by the fact that ultrasonographic data are unavailable in 16.3 % of the patients.
As for all case-control studies, the main limitation of our study is that the causality of the observed associations cannot be established. It is possible that in some instances, the elevation of biomarkers is the consequence, rather that the cause, of spontaneous miscarriage. We attempted to avoid this problem by measuring all biomarkers 6-12 months after the event, but formally this possibility cannot be excluded. A prospective study, in which biomarkers would be measured before conception, would resolve this issue, but would be logistically difficult to perform. Furthermore, which of the observed elevation in biomarkers represent a causal pathogenic mechanism, and which merely accompany such a mechanism, cannot be determined. It is worthless that the six independent predictors are not correlated, whether in cases or in controls, so that we have not so much identified a single syndrome as six independent risk factors. This for instance may reveal different
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There is a substantial overlap between the cases and controls, even with regard to those antibodies found statistically significant. This may lead to confusion in case of introduction of these assays as clinical tests. We propose, in the field of autoantibodies, a new attitude: not to define positive and negative values, but the presence of values in different risk-associated categories. However, on a practical point of view, this implies that clinical laboratories can detect normal values as precisely as abnormal values, and can discriminate values closed to multiple threshold values, even in the normal range. This also implies that the variability between tests results performed using different finally commercially-available kits can be controlled. This has to be proven, and our results need to be confirmed first in routine conditions.
In the previous NOHA 4 case-control study (11), performed in women with at least 3 episodes of pregnancy loss from the 8 th week of pregnancy, anti-2-glycoprotein I IgG was an independent risk factor but is not one in the present study. It may be that part of the information given by anti-2-glycoprotein I IgG is modified by anti-t-PA IgG. During in vivo activation of fibrinolysis, 2-glycoprotein I is cleaved, leading to the formation of molecular forms with a much lower affinity for negatively charged phospholipids (34): it may that autoimmunization against t-PA modifies the equilibrium between cleaved and native forms of 2-glycoprotein I and thus modifies autoimmunization against 2-glycoprotein I. Anticardiolipin IgM was not an independent risk factor in NOHA 4 study but is significant in the present one. The populations under focus are different. The current work is methodologically different, leading to identify increased risks associated with values of biomarkers thus so far considered as normal. Methodologically, our
For personal use only. on November 16, 2017. by guest www.bloodjournal.org From anticardiolipin assay uses fetal calf serum and not adult bovine serum as source of 2-glycoprotein I, a point which is known to influence the results of the assay (35). However, the fact that IgM anticardiolipin results were significant markers but IgG were not is contradictory to most findings in women with recurrent miscarriages: our findings must not be generalized to the recurrent miscarriage population.
A previous case-control study has suggested that women with a first spontaneous abortion are unlikely to have either lupus anticoagulant or IgG anticardiolipin antibodies (36). This work was not focused on the survival of a very early pregnancy. IgM anticardiolipin antibodies were not studied. The percentage of patients with a positive LA activity was close to our (5.1% vs. 6.5%) but the percentage of positive controls was significantly more important than our (3.8% vs. 1.3%). Table 4 . Univariate matched odds ratios for a first spontaneous abortion between 8 and 10 weeks of pregnancy.
(1). Table 5 . Univariate matched odds ratios for a first spontaneous abortion between 8 and 10 weeks of pregnancy.
(2). Non-traditional antiphospholipid antibodies and homocysteine. Table 6 . Univariate matched odds ratios for a first spontaneous abortion between 8 and 10 weeks of pregnancy.
(3). Anti-hemostasis-related key glycoproteins antibodies. Table 7 . Multivariate model * predicting a first spontaneous abortion between 8 and 10 weeks of pregnancy. * In 743 matched pairs; ** adjusted for variables.
*** Results of biomarkers with no international unit are given as the calculated slopes of the linear regressions describing the variation of absorbencies during the measurement interval. 
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